ESG Telegraph
  • Home
  • Latest News
  • Environment
  • Companies
  • Investors
  • Governance
  • Markets
  • Social
  • Regulators
  • Sustainable Finance
Featured Posts
    • Markets
    Uniper drops coal case as tensions rise over treaty on fossil fuel projects
    • August 15, 2022
    • Latest News
    Stock markets subdued after weaker than expected Chinese data
    • August 15, 2022
    • Companies
    Vanguard active funds suffer bloodiest first-half on record
    • August 15, 2022
    • Markets
    Why the Fed might be at ‘neutral’ already on monetary policy
    • August 15, 2022
    • Latest News
    Rio Tinto rebuffed in plan to take control of Mongolia copper project
    • August 15, 2022
Featured Categories
Belarussia
View Posts
Companies
View Posts
Energy
View Posts
Environment
View Posts
Food
View Posts
Governance
View Posts
Health
View Posts
Investors
View Posts
Latest News
View Posts
Markets
View Posts
Potash
View Posts
Regulators
View Posts
Russsia
View Posts
Social
View Posts
Supply Chain
View Posts
Sustainable Finance
View Posts
Technology
View Posts
Uncategorized
View Posts
ESG Telegraph ESG Telegraph
7K
9K
4K
1K
ESG Telegraph ESG Telegraph
  • Home
  • Latest News
  • Environment
  • Companies
  • Investors
  • Governance
  • Markets
  • Social
  • Regulators
  • Sustainable Finance
  • Markets

Chinese healthcare stocks sell off after US adds companies to ‘unverified’ list

  • February 8, 2022
  • Staff
Total
0
Shares
0
0
0

Shares in Chinese healthcare companies sold off after the US commerce department added pharmaceutical group WuXi Biologics to its “unverified” list for exporters, lopping off more than a fifth of the company’s market value.

The addition of WuXi and 32 other Chinese entities to a list that curbs their ability to access US technology sent Hong Kong’s Hang Seng Healthcare index down almost 5 per cent on Tuesday, putting it on track for its biggest drop since early December.

WuXi, a Chinese drugmaker, suspended trading of its Hong Kong-listed shares, which plummeted as much as 32 per cent. The company’s stock was down more than 22 per cent when its shares were frozen, wiping $10bn from its market capitalisation and putting it on track for its biggest daily decline on record.

The Biden administration has worked to make it more difficult for China to secure cutting-edge technologies by placing its companies on a series of entity lists and blacklists that restrict trade and investment.

Despite the sell-off, WuXi said in a public statement that its inclusion on the list would not significantly impact its business. “WuXi Biologics has been importing certain hardware controllers for bioreactors and certain hollow-fibre filters that are subject to US export controls but have received [US] approval for the last 10 years,” the company said in a statement late on Monday.

It added that the commerce department had “a routine process to verify the proper use . . . of these [materials] on site”, which had not been completed for two years as a result of the coronavirus pandemic.

The commerce department adds groups to its list if it cannot verify the end-use of goods exported to them. The addition of 33 Chinese groups to the unverified list came as the US steps up scrutiny of Chinese companies.

US exporters must apply for a licence if they want to export certain items to companies on the “unverified” list, while Chinese companies have to prove that they are in compliance with Washington’s regulations in order to be removed from it.

In December, the US added eight Chinese companies to its investment blacklist and 11 biopharmaceutical organisations to its “entity list”, which bans companies from exporting certain American technology.

But analysts said the impact of the bans could be minimised by replacing US components in any products. That is a potential path forward for WuXi, since the ban only affects two types of equipment used by the company.

John Yung, an analyst at Citigroup in Hong Kong, said WuXi was “more likely to seek alternatives in EU or China” rather than deal with expected delays for US parts as it sought the necessary approvals.

Unhedged — Markets, finance and strong opinion

Robert Armstrong dissects the most important market trends and discusses how Wall Street’s best minds respond to them. Sign up here to get the newsletter sent straight to your inbox every weekday

Total
0
Shares
Share 0
Tweet 0
Pin it 0
You May Also Like
Read More
  • Markets

Uniper drops coal case as tensions rise over treaty on fossil fuel projects

  • Staff
  • August 15, 2022
Read More
  • Markets

Why the Fed might be at ‘neutral’ already on monetary policy

  • Staff
  • August 15, 2022
Read More
  • Markets

Live news updates: Afghanistan marks a year of Taliban control

  • Staff
  • August 15, 2022
Read More
  • Markets

Saudi prince made $500mn Russia bet around start of Ukraine war

  • Staff
  • August 14, 2022
Read More
  • Markets

DR Congo opens oil and gas auction round to carbon credit and crypto groups

  • Staff
  • August 14, 2022
Read More
  • Markets

Did UK inflation pick up in July?

  • Staff
  • August 14, 2022
Read More
  • Markets

Storied City institution M&G looks ripe for a break-up

  • Staff
  • August 14, 2022
Read More
  • Markets

Asset managers curb pay amid rising cost pressures

  • Staff
  • August 14, 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Featured Posts
  • 1
    Uniper drops coal case as tensions rise over treaty on fossil fuel projects
    • August 15, 2022
  • 2
    Stock markets subdued after weaker than expected Chinese data
    • August 15, 2022
  • 3
    Vanguard active funds suffer bloodiest first-half on record
    • August 15, 2022
  • 4
    Why the Fed might be at ‘neutral’ already on monetary policy
    • August 15, 2022
  • 5
    Rio Tinto rebuffed in plan to take control of Mongolia copper project
    • August 15, 2022
Recent Posts
  • Digital advertising: Apple takes bigger bite of new business
    • August 15, 2022
  • At 75, India is finally ready to join the global party
    • August 15, 2022
  • Climate and crypto fraught with challenges for regulators 
    • August 15, 2022

Sign Up for Our Newsletters

Subscribe now to our newsletter

ESG Telegraph
  • Home
  • Privacy Policy
  • Guest Post
  • Contact

Input your search keywords and press Enter.